Research News: Keytruda® Promising in Advanced Head and Neck Cancer

Posted by cancerconnect @cancerconnect, Jun 11, 2015

The immunotherapy Keytruda® (pembrolizumab) appears active in the treatment of advanced squamous cell head and neck cancer. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago, Illinois) and published in the Journal of Clinical Oncology. Read more: http://news.cancerconnect.com/keytruda-promising-in-advanced-head-and-neck-cancer/

Interested in more discussions like this? Go to the Head and Neck Cancers group.

cityjimmy | @cityjimmy | Jan 27 9:08pm

Have we not read that in 2018 -+ finding of Libtayo to be first available treatment for squamous cell head, neck cancers? So is K. Truly more early use, is it compared to Libtayo , immune builder, by any writer/ researcher? J.

cityjimmy | @cityjimmy | Jan 28 5:37am

Link does not open.

charles | @charles | Jan 28 7:52am

In reply to @cityjimmy "Link does not open." + (show)

https://news.cancerconnect.com/head-neck-cancer/keytruda-precision-cancer-immunotherapy-treatment-for-head-and-neck-cancer

Please sign in or register to post a reply.